Peer-reviewed Publications 2025

1. Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard HF, Zangerle R, Vehreschild JJ, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski N, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O; RESPOND Study Group.
   Open Forum Infect Dis. 2025 Jan;12(2):ofaf016.  Abstract

2. A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV) Raben D, Jakobsen ML, Trajanovska J, Kowalska J, Vassilenko A, Dragas S, Harxhi A, Dragovic G, Jaschinski NJ, Neesgaard B, Hjorth-Larsen K, Garges H, Gallant J, Lundgren JD, Philips A, Cambiano V, Yazdanpanah Y, Mocroft A.
   PLoS One. 2025 Jan;20(1):e0316794.  Abstract

3. Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. Han WM, Ryom L, Sabin CA, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF.
   Clin Infect Dis. 2025 May:ciaf248. Epub ahead of print.   Abstract

4. Incident tuberculosis in people with HIV across Europe from 2012 to 2022: incidence rates, risk factors and regional differences in a multicentre cohort study.  Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen MC, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski N, Anne AV, Borodulina E, Ballif M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O; RESPOND Study Group.
   Eur Respir J. 2025 Jun;65(6):2401904.   Abstract

5. Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Mendes SDS, Tallada J, Kowalska J, Wallner E, Kusejko K, Naschinski N, Lundgren J, Peters L, Reekie J
   eClinicalMedicine 2025  Abstract

6. SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial). Sábato S, Benet S, Rogers AJ, Murray TA, Skeans M, Mothe B, Paredes R, Mourad A, Kiweewa F, Kamel D, Jain MK, Lutaakome J, Nalubega MG, Sebudde N, Mylonakis E, Braun DL, Hatlen T, Kimuli I, Kitko C, Mugerwa H, Kitonsa J, Kim K, Tien PC, Highbarger J, McCormack AL, Sanchez A, Murray DD, Babiker AG, Davey VJ, Files DC, Gelijns AC, Higgs ES, Kan VL, Matthews GV, Pett SL, Lane HC, Reilly C, Goodman AL, Lundgren JD, Moltó J; ACTIV-3/VATICO study group and the STRIVE Network.
   Sci Rep. 2025;15(1):9882.  Abstract

7. Genetics in a Danish Common Variable Immunodeficiency Cohort. Drabe CH, Laustsen MM, Marquart HV, Hartling HJ, Marvig RL, Helweg-Larsen J, Hansen AE, Lundgren J, Helleberg M, Borgwardt L, Katzenstein TL.
   J Clin Immunol. 2025;45(1):102.  Abstract

8. Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial. Mourad A, Grandits GA, Siegel LK, Engen N, Barkauskas C, Eriobu N, Jain MK, Jensen TO, Ginde A, Higgs E, Knox DB, Kitonsa J, Kim K, Malin JJ, Rapti V, Price DA, Mena Lora AJ, Mathews G, Mylonakis E, Murray TA, Sandkovsky U, Paredes R, Ramachandruni S, Reilly C, Vock D, Williamson JC, Young BE, Self WH, Lundgren J, Holland TL; INSIGHT ACTIV-3/TICO Study Group and the STRIVE Network.
   Clin Microbiol Infect. 2025;31(6):1053-1060.  Abstract

9. Functional immune reconstitution after allogeneic hematopoietic stem cell transplantation in myeloablative and non-myeloablative conditioned patients. Brooks PT, Minculescu L, Svanberg Teglgaard R, Hartling HJ, Salado-Jimena JA, Friis LS, Kornblit B, Schjødt I, Petersen SL, Andersen NS, Nielsen SD, Lundgren J, Marquart HV, Gjaerde LK, Sengeløv H, Ostrowski SR.
   Sci Rep. 2025;15(1):21029  Abstract

10. Immunogenicity and Safety of the COVID-19 mRNA Vaccine Coadministered with Influenza and 23-valent Pneumococcal Polysaccharide Vaccines. Rezahosseini O, Stæhr Jensen JU, Rahimi HK, Jensen NE, Jørgensen CS, Fischer TK, Ostrowski SR, Lundgren J, Ostergaard L, Harboe ZB.
    Clin Infect Dis. 2025:ciaf455. Epub ahead of print.  Abstract

11. The diagnostic value of soluble Epstein-Barr Virus BZLF1 protein (sZEBRA) in the Detection of Post-transplant lymphoproliferative Disease (PTLD) among Solid Organ (SOT) and Haematopoietic Cell (HSCT) Transplant Recipients. Wareham NE, Kjærgaard VS, Habib M, Reekie J, Rossing K, Sengeløv H, Buisson M, Lenormand JL, Perch M, Schultz N, Kirkby N, Sørensen SS, Lupo J, Lundgren JD, Murray DD, Drouet E.
    J Infect Dis. 2025 Sep:jiaf477. Epub ahead of print.  Abstract

12. Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study. Phillips AN, Bansi-Matharu L, van Oosterhout JJ, Hyle E, van de Vijver D, Kouyos R, Hong SY, Chun H, Raizes E, Kantor R, Jordan MR, Vitoria M, Ford N, Mugurungi O, Apollo T, Chimberengwa P, Meintjes G, Siedner M, Lundgren J, Schapiro J, Flexner C, Loosli T, Cambiano V, Smith J, Xia R, McCluskey S, Mewoabi S, Calmy A, Eholie SP, Revill P.
    Lancet HIV. 2025;12(8):e578-e586.  Abstract

13. Adenovirus Infections and Disease in Solid Organ Transplant Recipients: Incidence and Outcomes. Grarup KR, Schwartz Sørensen S, Perch M, Schultz N, Gustafsson F, Brix Christensen V, Schønning K, Sommerlund Moestrup K, Lundgren J, Crone CG, Helleberg M.
    Open Forum Infect Dis. 2025;12(2):ofaf032.  Abstract

14. Use of Preventive Measures for Cardiovascular Disease in People With HIV. Jaschinski N, Neesgaard B, Wit F, Van der Valk M, Kowalska J, Ridolfo AL, Günthard HF, Stöckle M, Wallner E, Nowak P, Castagna A, d'Arminio Monforte A, Petoumenos K, Hoy JF, Hosein S, Lundgren J, Garges H, Rogatto F, Young L, Peters L, Mocroft A, Ryom L; RESPOND Study Group.
    Open Forum Infect Dis. 2025;12(10):ofaf586.  Abstract

15. Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19. Paules CI, Nordwall JA, Shaw-Saliba K, Aberg JA, Gardner EM, Goodman AL, Kumarasamy N, Vasudeva S, Vock DM, North CM, Lundgren J, Aggarwal NR; STRIVE Network and TICO Trial Study Group.
    BMC Infect Dis. 2025;25(1):67.  Abstract

16. Possible scenarios for the spread of mpox outside the endemic focus in Africa. Petersen E, Hvid U, Tomori O, Pedersen AG, Wallinga J, Pebody R, Cenciarelli O, Aavitsland P, Van Laeken D, Andreasen V, Schneider U, Simonsen JK, Goedknegt MJF, Johannesen CK, Lundgren JD, Koch A, Søborg B, Ekström AM, Nohynek H, Aarestrup FM, Krause TG, Simonsen L.
    Int J Infect Dis. 2025;153:107373.  Abstract

17. The Gut Microbiome and Its Resistome as Predictors of Clinical Infections and Phenotypic Antibiotic Resistance in Hematopoietic Stem Cell Transplant Recipients. Nørgaard JC, Marandi RZ, Ilett EE, Gulay A, Paredes R, Lundgren JD, Jørgensen M, Sengeløv H.
    J Infect Dis. 2025;232(4):806-814.  Abstract

18. Associations Between Pre-Transplantation T Cell Populations and Acute Cellular Rejection Post-Liver Transplantation-Results From a Prospective Cohort Study. Scand J Immunol. Clemmesen JLR, Suarez-Zdunek MA, Møller DL, Hove-Skovsgaard M, Samuelsen S, Ostrowski SR, Willemoe GL, Pedersen CR, Lundgren J, Marquart HV, Hartling HJ, Rasmussen A, Nielsen SD.
    Scand J Immunol. 2025;102(2):e70048.  Abstract

19. Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup Røge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC.
    J Infect Dis. 2025;231(3):677-683.   Abstract

20. Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study. Jensen TO, Sharma S, Avihingsanon A, Lutaakome J, Brar I, Burman W, Chetchotisakd P, de Castro N, Galán-Herrera JF, Kumarasamy N, Paredes R, Ridzon R, Sciaudone M, Singh K, Uriel A, Lundgren J, Reilly C, Matthews G.
    Int J Infect Dis. 2025;156:107911.  Abstract

21. Post-tuberculosis lung disease patients benefit from vaccinations as other respiratory conditions. Migliori GB, Centis R, D'Ambrosio L, Visca D, Akkerman OW, Silva DR, Podlekareva D, Kherabi Y.
    Monaldi Arch Chest Dis. 2025. Epub ahead of print.  Abstract

22. Multi-drug resistant tuberculosis: where should we be with optimal treatment? Pontali E, Centis R, D'Ambrosio L, Silva DR, Podlekareva D, Migliori GB.
    Expert Rev Anti Infect Ther. 2025;23(7):425-428.   Abstract

23. Leukocyte count and new-onset diabetes mellitus in people with HIV: A longitudinal study.  Meyer SC, Klein Z, Schoepf IC, Thorball CW, Labarile M, Kootstra NA, Reiss P, Ryom L, Braun DL, Thurnheer MC, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Fellay J, Günthard HF, Kouyos RD, Ledergerber B, Tarr PE; Swiss HIV Cohort Study.
    HIV Med. 2025;26(10):1585-1599.   Abstract

24. Low Trauma Fractures in People with HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study 2009-2022.  Schoepf IC, Baltisberger V, Thorball CW, Ryom L, Wandeler G, Haerry D, Kahlert CR, Bernasconi E, Calmy A, Lamy O, Fellay J, Günthard HF, Ledergerber B, Tarr PE; Swiss HIV Cohort Study.
    Clin Infect Dis. 2025:ciaf392. Epub ahead of print  Abstract

25. Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease. Alagaratnam J, van Bremen K, Behrens GMN, Boccara F, Cinque P, Gisslén M, Guaraldi G, Konopnicki D, Kowalska JD, Mallon PWG, Marzolini C, Mendão L, Miró JM, Negredo E, Reiss P, Ryom L, van der Valk M, Winston A, Nielsen SD, Martínez E.
    Lancet HIV. 2025;12(5):e382-e392.  Abstract

26. The potential for annual long-acting HIV pre-exposure prophylaxis.  Ryom L.
    Lancet. 2025;405(10485):1120-1121.  Abstract

27. Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project. Malik S, Dorothea ZP, Argyropoulos CD, Themistocleous S, Macken AJ, Valdenmaiier O, Scheckenbach F, Bardach E, Pfeiffer A, Loens K, Ochando JC, Cornely OA, Demotes-Mainard J, Contrino S, Felder G.
    JMIR Med Inform. 2025 Mar 7;13:e65590.  Abstract

In Press

1. Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. Lorin Begré, Anders Boyd, Marie-Laure Plissonnier, Barbara Testoni, Charles Béguelin, Franziska Suter-Riniker, Caroline Scholtès, Jürgen K. Rockstroh, Karine Lacombe, Lars Peters, Marintha Heil, Massimo Levrero, Andri Rauch, Fabien Zoulim, Gilles Wandeler for the Swiss HIV Cohort study, EuroSIDA and French HIV/HBV and Biliver cohorts.
   JHEP Reports 2025 

2. Authors reply to “HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications“ Kraef C, Ryom L, Kirk O writing group and the RESPOND study group
   European Respiratory Journal, 2025 (in press) 

3. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Bonnet F, Lundgren J, Bottanelli M, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L for the D:A:D and RESPOND Study Groups
   Cancers, 2025. 17(24), 4000. (In press) 

4. Cancer Burden and Risk Factors Among Women with HIV: A Multi-regional Study from the D:A:D and RESPOND Cohort Collaborations Han WM, Neesgaard B, Knappik M, Cavassini M, Abela IA, Timiryasova A, Greenberg L, Martin C, Mussini C, Wit F, Sabin C, Castagna A, Abutidze A, El-Sadr, W, Bonnet F, Sarcletti M, Carlander C, Hachfeld A, Weis N, Vannappagari V, Rogatto FP, Young LA, Hosein SR, Ryom L, Petoumenos K, on behalf of the D:A:D and RESPOND collaborations
   eClinical Medicine 2025 (in press)